Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Booth Andrew
Chief Financial Officer at AbCellera Biologics. Filing since 9 Jun 2021.
CIK 0001834411
Company
Date
Role
Action
Shares
Amount
Of holding
ABCL
AbCellera Biologics Inc.
14 Aug 2026
Chief Financial Officer
Bought
37,200
$383.90K
8.3%
ABCL
AbCellera Biologics Inc.
27 Feb 2026
Chief Financial Officer
Bought
42,600
$145.69K
27.8%
ABCL
AbCellera Biologics Inc.
26 May 2023
Chief Financial Officer
Bought
14,500
$99.33K
10.5%
ABCL
AbCellera Biologics Inc.
12 May 2022
Chief Financial Officer
Bought
85,000
$492.15K
159%
ABCL
AbCellera Biologics Inc.
11 Nov 2021
Chief Financial Officer
Bought
53,500
$788.59K
opened
ABCL
AbCellera Biologics Inc.
11 Nov 2021
Chief Financial Officer
Bought
14,000
$204.54K
12.0%
ABCL
AbCellera Biologics Inc.
9 Jun 2021
Chief Financial Officer
Sold, plan not stated
1,200,000
$30.60M
100%
7 decisions on file.
